When done right, investing in pharmaceutical companies can be a lucrative endeavor. This is because as long as there are diseases and infections, medicines and vaccines will always remain in high demand. That builds a great deal of pricing power into the industry, which can in turn lead revenue and profits higher over the long run.

These two pharmaceutical companies both arguably possess the best of both worlds for industry investors: stacked product portfolios and promising product pipelines. Let's dig in.

Image source: Getty Images.

Continue reading

Source Fool.com